- Home
- IMVT vs HOG Comparison
IMVT vs HOG Comparison
Compare IMVT & HOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- HOG
- Stock Information
- Founded
- IMVT 2018
- HOG 1903
- Country
- IMVT United States
- HOG United States
- Employees
- IMVT N/A
- HOG N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- HOG Motor Vehicles
- Sector
- IMVT Health Care
- HOG Consumer Discretionary
- Exchange
- IMVT Nasdaq
- HOG Nasdaq
- Market Cap
- IMVT 2.7B
- HOG 2.8B
- IPO Year
- IMVT N/A
- HOG N/A
- Fundamental
- Price
- IMVT $16.00
- HOG $26.83
- Analyst Decision
- IMVT Buy
- HOG Buy
- Analyst Count
- IMVT 10
- HOG 7
- Target Price
- IMVT $33.38
- HOG $30.00
- AVG Volume (30 Days)
- IMVT 1.7M
- HOG 1.7M
- Earning Date
- IMVT 11-06-2025
- HOG 10-23-2025
- Dividend Yield
- IMVT N/A
- HOG 2.69%
- EPS Growth
- IMVT N/A
- HOG N/A
- EPS
- IMVT N/A
- HOG 1.93
- Revenue
- IMVT N/A
- HOG $4,474,610,000.00
- Revenue This Year
- IMVT N/A
- HOG N/A
- Revenue Next Year
- IMVT N/A
- HOG $4.11
- P/E Ratio
- IMVT N/A
- HOG $13.92
- Revenue Growth
- IMVT N/A
- HOG N/A
- 52 Week Low
- IMVT $12.72
- HOG $20.45
- 52 Week High
- IMVT $32.10
- HOG $36.94
- Technical
- Relative Strength Index (RSI)
- IMVT 50.79
- HOG 37.81
- Support Level
- IMVT $15.81
- HOG $27.89
- Resistance Level
- IMVT $17.15
- HOG $29.22
- Average True Range (ATR)
- IMVT 0.73
- HOG 0.95
- MACD
- IMVT 0.10
- HOG -0.35
- Stochastic Oscillator
- IMVT 57.98
- HOG 7.32
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About HOG Harley-Davidson Inc.
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring segments, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 37% of the heavyweight domestic market in 2024.